SE7905375L - Antitumorkompositioner for icke-injektionsadministrering - Google Patents

Antitumorkompositioner for icke-injektionsadministrering

Info

Publication number
SE7905375L
SE7905375L SE7905375A SE7905375A SE7905375L SE 7905375 L SE7905375 L SE 7905375L SE 7905375 A SE7905375 A SE 7905375A SE 7905375 A SE7905375 A SE 7905375A SE 7905375 L SE7905375 L SE 7905375L
Authority
SE
Sweden
Prior art keywords
injection administration
antitumor compositions
administration antitumor
compositions
arabinofuranosylcytosine
Prior art date
Application number
SE7905375A
Other languages
English (en)
Other versions
SE455162B (sv
Inventor
K Kodama
A Kuninaka
M Saneyoshi
Original Assignee
Yamasa Shoyu Kk
Saneyoshi Mineo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamasa Shoyu Kk, Saneyoshi Mineo filed Critical Yamasa Shoyu Kk
Publication of SE7905375L publication Critical patent/SE7905375L/sv
Publication of SE455162B publication Critical patent/SE455162B/sv

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
SE7905375A 1978-06-20 1979-06-19 Antitumorkomposition i form av ett oralt farmaceutiskt preparat eller ett suppositorium, innehallande en ester av 1-beta-d-arabinofuranosylcytosin-5'-fosfat SE455162B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7369878A JPS552601A (en) 1978-06-20 1978-06-20 Anti-tumor agent for non-injection use

Publications (2)

Publication Number Publication Date
SE7905375L true SE7905375L (sv) 1979-12-21
SE455162B SE455162B (sv) 1988-06-27

Family

ID=13525685

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7905375A SE455162B (sv) 1978-06-20 1979-06-19 Antitumorkomposition i form av ett oralt farmaceutiskt preparat eller ett suppositorium, innehallande en ester av 1-beta-d-arabinofuranosylcytosin-5'-fosfat

Country Status (9)

Country Link
US (1) US4542021A (sv)
JP (1) JPS552601A (sv)
CH (1) CH638982A5 (sv)
DE (1) DE2924691A1 (sv)
FR (1) FR2429019A1 (sv)
GB (1) GB2023422B (sv)
IT (1) IT1206968B (sv)
NL (1) NL190955C (sv)
SE (1) SE455162B (sv)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10370401B2 (en) 2013-10-11 2019-08-06 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS552602A (en) * 1978-06-20 1980-01-10 Yamasa Shoyu Co Ltd 1-beta-d-arabinofranosylcytosine-5'-phosphoric acid oleyl ester
EP0081386B1 (en) * 1981-12-09 1985-05-29 Teijin Limited 5-fluoro-2'-deoxyuridine derivatives and a process for the preparation thereof
JPS58225097A (ja) * 1982-06-23 1983-12-27 Yamasa Shoyu Co Ltd ヌクレオシド5′−アルキルもしくはアルケニルりん酸
JPS5925327A (ja) * 1982-07-31 1984-02-09 Hidematsu Hirai 抗腫瘍性複合体の製造方法
EP0239015B1 (en) * 1986-03-24 1991-10-16 Nippon Kayaku Kabushiki Kaisha Process for producing 1-beta-d-arabinofuranosylcytosine-5'-stearylphosphate monosodium salt and monohydrate thereof, and pharmaceutical composition containing the latter
ES2160582T3 (es) * 1992-04-03 2001-11-16 Nippon Kayaku Kk Capsula dura de ocfosfato de citarabina.
DE4402492A1 (de) * 1994-01-28 1995-08-03 Boehringer Mannheim Gmbh Verfahren zur Herstellung von unsymmetrischen Phosphorsäurediestern
GB2389788B (en) * 2000-12-23 2005-07-20 Univ Creighton Methods for inducing apoptosis and inhibiting proliferation in cancer cells
US20040072902A1 (en) * 2001-12-24 2004-04-15 Adrian Thomas E. Methods for inducing apoptosis and inhibiting proliferation in cancer cells
US7524831B2 (en) * 2005-03-02 2009-04-28 Schering Corporation Treatments for Flaviviridae virus infection
CN102115485A (zh) * 2009-12-30 2011-07-06 济南圣鲁金药物技术开发有限公司 基于阿糖胞苷结构的前药及其合成方法及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1792447C3 (de) * 1968-09-04 1978-05-11 Fa. Heinrich Mack Nachf., 7919 Au Oral anwendbares, cytostatisches Mittel
DE2438322C3 (de) * 1974-08-09 1979-02-08 Chemische Werke Huels Ag, 4370 Marl Verfahren zur Herstellung von Polymerisaten mit breiter Molekulargewichtsverteilung
DE2546073A1 (de) * 1974-10-15 1976-04-22 Asahi Chemical Ind Nucleotid-derivate und verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
JPS5289681A (en) * 1976-01-22 1977-07-27 Yamasa Shoyu Co Ltd Preparation of aracytidine -5# phosphoric acid ester derivatives
JPS552602A (en) * 1978-06-20 1980-01-10 Yamasa Shoyu Co Ltd 1-beta-d-arabinofranosylcytosine-5'-phosphoric acid oleyl ester

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10370401B2 (en) 2013-10-11 2019-08-06 Janssen Biopharma, Inc. Substituted nucleosides, nucleotides and analogs thereof

Also Published As

Publication number Publication date
GB2023422B (en) 1983-01-06
DE2924691C2 (sv) 1991-10-10
NL190955B (nl) 1994-06-16
US4542021A (en) 1985-09-17
IT7949442A0 (it) 1979-06-18
NL7904771A (nl) 1979-12-27
CH638982A5 (fr) 1983-10-31
DE2924691A1 (de) 1980-01-17
FR2429019B1 (sv) 1982-11-05
GB2023422A (en) 1980-01-03
JPS552601A (en) 1980-01-10
SE455162B (sv) 1988-06-27
FR2429019A1 (fr) 1980-01-18
JPS5748091B2 (sv) 1982-10-14
NL190955C (nl) 1994-11-16
IT1206968B (it) 1989-05-17

Similar Documents

Publication Publication Date Title
US4302465B1 (sv)
KR840001156A (ko) 벤지미다졸 유도체의 제조방법
SE7905375L (sv) Antitumorkompositioner for icke-injektionsadministrering
DE3062452D1 (en) Branched fatty acid cholesterol ester and a cosmetic composition containing the same
ES8505650A1 (es) Un metodo de producir una emulsion grasa que contiene ester alquilico de prostaglandina e1
PT74078A (en) Process for preparing 4-pregnene-derivatives and pharmaceutical compositions containing the same
ES8106289A1 (es) Procedimiento de preparacion de nuevos derivados del a-fe- nil-2-pirrolidin-metanol
ES8504778A1 (es) Un procedimiento para la preparacion de derivados de fenil-piperazina
GB1497218A (en) Thiaprostaglandins
ES8506706A1 (es) Procedimiento para la obtencion de esteres sustituidos de tiazolidimilos de acidos minerales.
SE7902867L (sv) Antikomplementera medel
FR2499076B1 (sv)
DE3160968D1 (en) Cardenolide-bis-digitoxoside derivatives, process for their preparation and their utilization as medicines
KR950702566A (ko) 사슬형 아미딘기를 포함하는 디포스폰산 유도체, 그것의 제조방법 및 그것을 포함하는 의약 조성물(novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds)
SE7706693L (sv) Sett att framstella hydrazinopyridazinderivat
ES445343A1 (es) Procedimiento para la preparacion de derivados cuaternarios de xantinil-alcohil-nortropina.
ES407867A1 (es) Procedimiento para la obtencion de derivados de la fenotia-zina.
ES399726A1 (es) Procedimiento para la preparacion de compuestos para ali- viar sintomas de la enfermedad de parkinson.
DE3175939D1 (en) Use of gamma-piperidino-butyrophenones for the preparation of medicaments for treating diarrhoea
ES458932A1 (es) Procedimiento para la obtencion de derivados del 2-oxa-7,9- diaza-bicilo (4,2,2) decano.
SE8206945L (sv) Nya i position 5 substituerade tetrazolderivat, deras framstellningssett och terapeutiska anvendning
KR830000705A (ko) 멀아밀-펲타이드형태인 신규 화합물의 제조방법
ES423976A1 (es) Procedimiento para la preparacion de nuevas bencilaminas.
IL74542A0 (en) Carbacyclin derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ES467409A1 (es) Procedimiento de preparacion de derivados de la ajmalicina.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7905375-7

Format of ref document f/p: F